A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.
Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Windsong Radiology Group President Dr. Raja Cheruvu became ...
—Findings from a recent study suggest that management of prostate cancer has improved in the last 2 decades, including a lower frequency of pathologic grade group 1 prostatectomies. The number of ...
A BREAKTHROUGH IN PROSTATE CANCER TREATMENT IS NOW AVAILABLE RIGHT HERE IN CINCINNATI, AND ONE LOCAL HOSPITAL AND DOCTOR ARE UTILIZING IT WITH EARLY SUCCESS. WLWT NEWS FIVE’S MEGAN MITCHELL SPOKE WITH ...
Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to rise over the coming decades. But in a recent Urologic Oncology article, ...
Prostate cancer is the most commonly diagnosed cancer in the UK. But screening is not universal, and charities are divided over whether it should be extended. What do those living with the disease ...
A multi-institutional clinical trial showed that a newer technique for collecting prostate biopsy samples reduced the risk of infection compared with traditional biopsy approaches. A ...
DEAR DR. ROACH: Regarding your recent column about prostate cancer, could you please clarify a statement that has created some concern and confusion for me? The statement is: “Screening begins to have ...
"Cancer took my dad when he was 56. I was 24 then. I came to believe I would be denied a long life, too. I didn’t admit that to people," columnist Terry Woster writes.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results